Key facts
- Optellum has surpassed 250 clinical sites.
- Optellum has analyzed over 3 million cases to date.
- Optellum utilizes AI for lung cancer diagnostics.
Optellum, a company specializing in AI-driven lung cancer diagnostics, announced a significant expansion of its reach. The company has now been implemented in over 250 clinical sites and has processed more than 3 million patient cases. This growth highlights Optellum's expanding role in improving lung cancer detection and care through artificial intelligence. The company is committed to advancing diagnostic capabilities in oncology.